4.7 Review

Beyond Prostate Cancer: An Androgen Receptor Splice Variant Expression in Multiple Malignancies, Non-Cancer Pathologies, and Development

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Cell Biology

Mouse-human species differences in early testicular development and its implications

Gerald R. Cunha et al.

Summary: It has been assumed that mouse organogenesis can serve as a model for human organogenesis, but there are significant anatomical, morphogenetic, and molecular differences between mice and humans. This study compares the development of testicles in mice and humans, focusing on differences in the formation of different cell types. It provides a detailed comparison of early testicular development in mice and humans.

DIFFERENTIATION (2023)

Review Chemistry, Medicinal

Targeting the N-terminal domain of the androgen receptor: The effective approach in therapy of CRPC

Yang Ji et al.

Summary: This review discusses various inhibitors targeting the AR N-terminal domain and their significance in overcoming resistance mechanisms in prostate cancer treatment.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Urology & Nephrology

Disparities and Trends in Genitourinary Cancer Incidence and Mortality in the USA

Elizabeth J. Schafer et al.

Summary: This study examined disparities and trends in the incidence and mortality rates of the four major genitourinary cancers (bladder, kidney, prostate, and testis) in the USA. The study found gender, racial/ethnic, and regional differences in the incidence and mortality rates of these cancers, as well as unfavorable trends. This study is important for understanding the epidemiological characteristics and influencing factors of these tumors.

EUROPEAN UROLOGY (2023)

Article Multidisciplinary Sciences

Androgen receptor-dependent regulation of metabolism in high grade bladder cancer cells

Kimberley D. Katleba et al.

Summary: The sex disparity in bladder cancer implies the involvement of androgen receptor (AR) signaling in these malignancies. Different forms of AR regulate partially overlapping transcriptional programs, including the decrease of mTOR and the increase of hypoxia-regulated transcripts. Niclosamide, identified as an ATPase inhibitor in a compound library, shows potential for targeting the AR downstream vulnerability and limiting bladder cancer.

SCIENTIFIC REPORTS (2023)

Article Oncology

Cancer statistics, 2023

Rebecca L. Siegel et al.

Summary: The American Cancer Society predicts that there will be 1,958,310 new cancer cases and 609,820 cancer deaths in the United States in 2023. While incidence trends for most cancers are favorable, prostate cancer saw a significant increase of 3% annually from 2014 to 2019. However, the overall cancer death rate continues to decline due to advances in treatment, with a 33% reduction since 1991.

CA-A CANCER JOURNAL FOR CLINICIANS (2023)

Review Oncology

Targeting the Androgen Signaling Axis in Prostate Cancer

Charles Dai et al.

Summary: The activation of androgen receptor (AR) and AR-driven transcriptional programs play critical roles in the pathophysiology of prostate cancer. However, therapeutic resistance often occurs due to molecular alterations in the androgen signaling axis. The efficacy of next-generation AR-directed therapies provides validation for the dependence on AR signaling, but metastatic prostate cancer remains incurable. Therefore, it is important to understand the diverse mechanisms by which tumors resist AR-directed therapies to find new treatment options.

JOURNAL OF CLINICAL ONCOLOGY (2023)

Review Endocrinology & Metabolism

Deconstructing a Syndrome: Genomic Insights Into PCOS Causal Mechanisms and Classification

Matthew Dapas et al.

Summary: Polycystic ovary syndrome (PCOS) is a common disorder in women of reproductive age, characterized by reproductive abnormalities, insulin resistance, and obesity. Genetic and environmental factors contribute to the development of PCOS. Genomic studies have provided insights into disease pathways and highlighted the limitations of current diagnostic criteria. Future research will focus on understanding the genetic mechanisms of PCOS.

ENDOCRINE REVIEWS (2022)

Review Pharmacology & Pharmacy

Advances with androgen deprivation therapy for prostate cancer

Eun-mi Yu et al.

Summary: Androgen deprivation therapy (ADT) is a commonly used treatment for prostate cancer, with the main method being the use of gonadotropin-releasing hormone (GnRH) agonists.

EXPERT OPINION ON PHARMACOTHERAPY (2022)

Article Pathology

Androgen receptor splice variant-7 in breast cancer: clinical and pathologic correlations

Donna C. Ferguson et al.

Summary: The prevalence of AR-V7 in breast cancer is 9.7%, with a correlation to AR positivity and apocrine morphology. Notably, AR-V7 was detected in both primary and metastatic/recurrent breast cancer patients without prior endocrine therapy, suggesting potential implications for targeted treatment.

MODERN PATHOLOGY (2022)

Article Multidisciplinary Sciences

Cistrome and transcriptome analysis identifies unique androgen receptor (AR) and AR-V7 splice variant chromatin binding and transcriptional activities

Paul Basil et al.

Summary: The constitutively active androgen receptor splice variant AR-V7 is involved in resistance to androgen deprivation therapy in CRPC. This study compares the activities of AR and AR-V7 using cell lines with matched expression levels. The two isoforms have both shared and distinct transcriptomes and cistromes, with AR-V7 showing unique binding sites.

SCIENTIFIC REPORTS (2022)

Review Endocrinology & Metabolism

What Does Androgen Receptor Signaling Pathway in Sertoli Cells During Normal Spermatogenesis Tell Us?

Jia-Ming Wang et al.

Summary: The androgen receptor signaling pathway is crucial for spermatogenesis in the testes. Sertoli cells, the only somatic cell type in seminiferous tubules, are regulated by this pathway, which affects both Sertoli and germ cells. The pathway plays roles in Sertoli cell proliferation and maturation, as well as the integrity of the blood-testis barrier. Meiotic and post-meiotic processes are also regulated by this pathway, ensuring the development and release of mature sperm.

FRONTIERS IN ENDOCRINOLOGY (2022)

Review Cell Biology

Analyzing the Androgen Receptor Interactome in Prostate Cancer: Implications for Therapeutic Intervention

Ujjwal R. Dahiya et al.

Summary: The androgen receptor (AR) plays a crucial role in male phenotype development and diseases, including prostate cancer. Therapeutic approaches targeting the interaction between AR and its ligands show promise, but face challenges. Understanding the 3D structure of AR complexes and protein interaction sites is essential for developing effective interventions.
Review Biochemistry & Molecular Biology

Modulating the Activity of Androgen Receptor for Treating Breast Cancer

Chan-Ping You et al.

Summary: Activation of the androgen receptor (AR) can suppress disease progression in estrogen receptor alpha-positive breast cancer, while blocking AR might provide better prognosis in estrogen receptor alpha-negative breast cancer. Modulating AR activity could be a potential strategy for treating breast cancer.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Review Biochemistry & Molecular Biology

Constitutively Active Androgen Receptor in Hepatocellular Carcinoma

Emma J. Montgomery et al.

Summary: Hepatocellular carcinoma (HCC) is a common type of liver cancer and a leading cause of cancer-related death worldwide. The androgen receptor (AR) has been found to play an important role in HCC, although current AR-targeted therapies have not shown efficacy in HCC. However, by building upon research in prostate cancer (PCa), potential AR-targeted therapeutic approaches for HCC could be developed.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Oncology

Phase II Study of Enzalutamide for Patients With Androgen Receptor-Positive Salivary Gland Cancers (Alliance A091404)

Alan L. Ho et al.

Summary: This study evaluated the efficacy of the antiandrogen enzalutamide in patients with androgen receptor-positive salivary gland cancer. The results showed limited activity of enzalutamide in this type of cancer, highlighting the need for strategies to enhance the effectiveness of antiandrogen therapy.

JOURNAL OF CLINICAL ONCOLOGY (2022)

Review Immunology

Sex bias in lymphocytes: Implications for autoimmune diseases

Katherine C. Dodd et al.

Summary: Autoimmune diseases show significant sex dimorphism, with women being more susceptible. This is partly caused by complex interactions between sex hormones and sex chromosomes, as well as sociological factors, diet, and gut microbiota.

FRONTIERS IN IMMUNOLOGY (2022)

Review Endocrinology & Metabolism

Sexual dimorphism through androgen signaling; from external genitalia to muscles

Lerrie Ann Ipulan-Colet

Summary: Sexual dimorphisms are observed in many organisms, with differences in morphology and reproductive structures between males and females. Androgen signaling plays a crucial role in the development of the genital tubercle and is also involved in regulating sexual dimorphism in muscle development, although the specific mechanisms are still unclear.

FRONTIERS IN ENDOCRINOLOGY (2022)

Review Oncology

A Systematic Review of Circulating Tumor Cells Clinical Application in Prostate Cancer Diagnosis

Dmitry Enikeev et al.

Summary: Liquid biopsy, which combines cell-dependent and cell-independent information from the blood stream, has the potential to revolutionize cancer management. However, the science behind liquid biopsies is not widely utilized. In this systematic review, the use of CTCs in prostate cancer management was summarized, highlighting their predictive value for disease progression, survival, and response to therapy.

CANCERS (2022)

Article Biology

Gonadal sex patterns p21-induced cellular senescence in mouse and human glioblastoma

Lauren Broestl et al.

Summary: Males have higher incidence and worse prognosis for most cancers, including glioblastoma (GBM). The study shows that female cells are more sensitive to radiation and senescence plays a major role in radiation therapeutic response in both sexes. Differences in CDK inhibitor p21 and irradiation-induced senescence regulation between male and female cells were observed. The findings suggest that exploring sex differences in radiation response and enhancing senescence for radiation sensitization could be beneficial.

COMMUNICATIONS BIOLOGY (2022)

Review Urology & Nephrology

Androgen Receptor Signaling Inhibitors in Addition to Docetaxel with Androgen Deprivation Therapy for Metastatic Hormone-sensitive Prostate Cancer: A Systematic Review and Meta-analysis

Takafumi Yanagisawa et al.

Summary: This study examined the efficacy of triplet combination therapy using androgen receptor signaling inhibitors (ARSIs) with docetaxel (DOC) and androgen deprivation therapy (ADT) in patients with metastatic hormone-sensitive prostate cancer (mHSPC). Through meta-analyses and network meta-analyses (NMAs), it was found that triplet therapy outperformed doublet therapy in terms of overall survival (OS) and progression-free survival (PFS). Additionally, the efficacy varied among different patient subgroups. However, further confirmation through larger-scale and longer-term follow-up trials is needed.

EUROPEAN UROLOGY (2022)

Article Urology & Nephrology

Testosterone and the Androgen Receptor

Thomas Gerald et al.

Summary: Testosterone and its steroid metabolite hormones play a crucial role in the development of male sexual characteristics and function, as well as in maintaining homeostasis in multiple organ systems. Researchers have made significant progress in understanding its production, mechanism of action, and metabolism, as well as its implications in normal physiological and pathological processes.

UROLOGIC CLINICS OF NORTH AMERICA (2022)

Review Oncology

In Vivo Models for Prostate Cancer Research

Robert Adamiecki et al.

Summary: This review examines the in vivo models of prostate cancer, specifically focusing on recently proposed mouse models. The comparison and analysis of these models provides researchers with valuable information to inform their future studies on prostate cancer. The review also highlights the importance of incorporating various types of models to enhance our understanding of prostate cancer.

CANCERS (2022)

Review Oncology

Addition of Docetaxel to Androgen Receptor Axis-targeted Therapy and Androgen Deprivation Therapy in Metastatic Hormone-sensitive Prostate Cancer: A Network Meta-analysis

Soumyajit Roy et al.

Summary: This study compared the efficacy of ADT plus ARAT with the triplet of ADT, ARAT, and docetaxel in mHSPC through a network meta-analysis. The triplet was ranked as the most effective treatment strategy, but it did not show a statistically significant overall survival benefit compared to ADT plus ARAT.

EUROPEAN UROLOGY ONCOLOGY (2022)

Article Oncology

Survival benefit of HER2-targeted or androgen deprivation therapy in salivary duct carcinoma

Daisuke Kawakita et al.

Summary: This retrospective study analyzed the treatment outcomes of 323 patients with locally advanced, recurrent, or metastatic salivary duct carcinoma (SDC). The results showed that patients treated with HER2-targeted therapy and androgen deprivation therapy (ADT) had longer overall survival. HER2-targeted therapy can be recommended as first-line treatment for HER2-positive/AR-positive SDC.

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2022)

Article Biology

Differential Expression of the Androgen Receptor, Splice Variants and Relaxin 2 in Renal Cancer

Joanna Bialek et al.

Summary: The study found that clear cell RCC tissues expressed AR and its splice variants more frequently than papillary RCC tissues, with specific AR variants correlating with tumor staging and RLN2 expression in males. Furthermore, the secretion pattern of the proinflammatory cytokine IL-6 was higher in ccRCC than in pRCC, suggesting potential differences in the molecular mechanisms between the two types of kidney cancer.

LIFE-BASEL (2021)

Review Endocrinology & Metabolism

The Role of Androgen Signaling in Male Sexual Development at Puberty

Rodolfo A. Rey

Summary: Puberty is characterized by major changes in the anatomy and function of reproductive organs, with androgen playing a crucial role in this process.

ENDOCRINOLOGY (2021)

Article Evolutionary Biology

Why women have more autoimmune diseases than men: An evolutionary perspective

Vanessa L. Kronzer et al.

Summary: Women have a higher risk of autoimmune diseases compared to men, possibly due to differences in circulating antibodies. This may be linked to an evolutionary mechanism of protecting offspring from infections, which could explain the prevalence of autoimmunity in women and open up new treatment possibilities.

EVOLUTIONARY APPLICATIONS (2021)

Article Biochemistry & Molecular Biology

The androgen receptor is a tumor suppressor in estrogen receptor-positive breast cancer

Theresa E. Hickey et al.

Summary: Studies have shown that androgen receptor (AR) plays a tumor suppressor role in estrogen receptor (ER)-positive breast cancer, with AR activation helping to suppress cell cycle genes and promote the expression of tumor suppressor genes, enhancing therapeutic responses.

NATURE MEDICINE (2021)

Article Developmental Biology

Identification of placental androgen receptor isoforms in a sheep model of maternal allergic asthma

Ashley S. Meakin et al.

Summary: The study found that maternal asthma affects the expression and subcellular distribution of androgen receptor isoforms in sheep placenta, highlighting the importance of understanding molecular patterns that may impact feto-placental growth and development in in vivo models of maternal asthma.

PLACENTA (2021)

Article Oncology

Depletion of androgen receptor low molecular weight isoform reduces bladder tumor cell viability and induces apoptosis

Kimberley Katleba et al.

Summary: Bladder cancer cells express low molecular weight AR isoforms, including a novel AR-LMW variant AR-v19, which play a role in promoting cell survival and transcriptional activation in the nucleus. Targeting AR or its downstream effectors may be a potential therapeutic strategy for treating this malignancy.

CANCER LETTERS (2021)

Article Chemistry, Medicinal

Exploration and Biological Evaluation of Basic Heteromonocyclic Propanamide Derivatives as SARDs for the Treatment of Enzalutamide-Resistant Prostate Cancer

Yali He et al.

Summary: A series of propanamide derivatives were designed, synthesized, and characterized as selective androgen receptor degraders (SARDs) and pan-antagonists, showing efficacy against enzalutamide-resistant prostate cancers.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Review Oncology

AR Splicing Variants and Resistance to AR Targeting Agents

Mayuko Kanayama et al.

Summary: Androgen receptor splice variants (AR-Vs) play a crucial role in prostate cancer progression, particularly as a resistance mechanism against AR-targeted therapies. Advances in prostate cancer research have led to the discovery of novel biomarkers and effective treatments, emphasizing the importance of further developing and utilizing optimal biomarkers for treatment optimization.

CANCERS (2021)

Review Oncology

Sex and Gender Differences in Kidney Cancer: Clinical and Experimental Evidence

Anna Julie Peired et al.

Summary: Kidney cancer is a common malignant tumor, with males being twice as likely to develop the disease compared to females. This difference may stem from genetics or pathologies. Understanding these sex-based differences is essential for providing personalized medical care.

CANCERS (2021)

Article Cell Biology

Evolution of the androgen receptor: Perspectives from human health to dancing birds

Eric R. Schuppe et al.

MOLECULAR AND CELLULAR ENDOCRINOLOGY (2020)

Review Endocrinology & Metabolism

Sex differences in cancer mechanisms

Joshua B. Rubin et al.

BIOLOGY OF SEX DIFFERENCES (2020)

Review Immunology

Influence of Androgens on Immunity to Self and Foreign: Effects on Immunity and Cancer

Isabel Ben-Batalla et al.

FRONTIERS IN IMMUNOLOGY (2020)

Review Gastroenterology & Hepatology

Alternative Splicing in Hepatocellular Carcinoma

Seung Eun Lee et al.

CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2020)

Article Oncology

5α-reductase inhibitors impact prognosis of urothelial carcinoma

Chien-Sheng Wang et al.

BMC CANCER (2020)

Article Biochemistry & Molecular Biology

Structural Insights of Transcriptionally Active, Full-Length Androgen Receptor Coactivator Complexes

Xinzhe Yu et al.

MOLECULAR CELL (2020)

Review Physiology

11-Keto-testosterone and Other Androgens of Adrenal Origin

Luboslav Starka et al.

PHYSIOLOGICAL RESEARCH (2020)

Article Biotechnology & Applied Microbiology

Dihydrotestosterone Induces Proliferation, Migration, and Invasion of Human Glioblastoma Cell Lines

DulceCarolina Rodriguez-Lozano et al.

ONCOTARGETS AND THERAPY (2020)

Review Biochemistry & Molecular Biology

The Androgen Receptor in Prostate Cancer: Effect of Structure, Ligands and Spliced Variants on Therapy

Elisabeth A. Messner et al.

BIOMEDICINES (2020)

Review Oncology

Genome-Wide Sex and Gender Differences in Cancer

Camila M. Lopes-Ramos et al.

FRONTIERS IN ONCOLOGY (2020)

Review Immunology

An Inconvenient Variable: Sex Hormones and Their Impact on T Cell Responses

Melissa A. Brown et al.

JOURNAL OF IMMUNOLOGY (2019)

Article Developmental Biology

Human placental androgen receptor variants: Potential regulators of male fetal growth

Ashley S. Meakin et al.

PLACENTA (2019)

Article Endocrinology & Metabolism

Testosterone Promotes Glioblastoma Cell Proliferation, Migration, and Invasion Through Androgen Receptor Activation

Dulce Carolina Rodriguez-Lozano et al.

FRONTIERS IN ENDOCRINOLOGY (2019)

Review Oncology

Sex-Based Heterogeneity in Response to Lung Cancer Immunotherapy: A Systematic Review and Meta-Analysis

Fabio Conforti et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)

Article Multidisciplinary Sciences

Androgens Induce Invasiveness of Triple Negative Breast Cancer Cells Through AR/Src/PI3-K Complex Assembly

Pia Giovannelli et al.

SCIENTIFIC REPORTS (2019)

Article Biochemistry & Molecular Biology

LIN28B regulates androgen receptor in human trophoblast cells through Let-7c

Erin S. McWhorter et al.

MOLECULAR REPRODUCTION AND DEVELOPMENT (2019)

Review Biochemistry & Molecular Biology

Sex Differences in Cancer Immunotherapy Efficacy, Biomarkers, and Therapeutic Strategy

Shixiang Wang et al.

MOLECULES (2019)

Article Otorhinolaryngology

Androgen deprivation therapy for androgen receptor-positive advanced salivary duct carcinoma: A nationwide case series of 35 patients in The Netherlands

Eline Boon et al.

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2018)

Review Endocrinology & Metabolism

Circulating Testosterone as the Hormonal Basis of Sex Differences in Athletic Performance

David J. Handelsman et al.

ENDOCRINE REVIEWS (2018)

Article Oncology

Enzalutamide for the Treatment of Androgen Receptor-Expressing Triple-Negative Breast Cancer

Tiffany A. Traina et al.

JOURNAL OF CLINICAL ONCOLOGY (2018)

Article Oncology

AR Expression in Breast Cancer CTCs Associates with Bone Metastases

Nicola Aceto et al.

MOLECULAR CANCER RESEARCH (2018)

Review Immunology

Glucocorticoids, Sex Hormones, and immunity

Oxana Bereshchenko et al.

FRONTIERS IN IMMUNOLOGY (2018)

Review Oncology

Alternative splicing in prostate cancer

Alec Paschalis et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2018)

Review Biochemistry & Molecular Biology

The nuclear receptor superfamily: A structural perspective

Emily R. Weikum et al.

PROTEIN SCIENCE (2018)

Article Urology & Nephrology

Variability of Sex Disparities in Cancer Incidence over 30 Years: The Striking Case of Kidney Cancer

Ghislaine Scelo et al.

EUROPEAN UROLOGY FOCUS (2018)

Review Oncology

Androgen deprivation and immunotherapy for the treatment of prostate cancer

Melissa Gamat et al.

ENDOCRINE-RELATED CANCER (2017)

Article Obstetrics & Gynecology

Subcutaneous testosterone-letrozole therapy before and concurrent with neoadjuvant breast chemotherapy: clinical response and therapeutic implications

Rebecca L. Glaser et al.

MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2017)

Article Oncology

Synergy between Androgen Receptor Antagonism and Inhibition of mTOR and HER2 in Breast Cancer

Michael A. Gordon et al.

MOLECULAR CANCER THERAPEUTICS (2017)

Article Biochemistry & Molecular Biology

Development of cell-penetrating bispecific antibodies targeting the N-terminal domain of androgen receptor for prostate cancer therapy

Nancy L. Goicochea et al.

PROTEIN ENGINEERING DESIGN & SELECTION (2017)

Article Multidisciplinary Sciences

The effect of androgen excess on maternal metabolism, placental function and fetal growth in obese dams

Romina Fornes et al.

SCIENTIFIC REPORTS (2017)

Article Neurosciences

Presence of Androgen Receptor Variant in Neuronal Lipid Rafts

Jo Garza-Contreras et al.

ENEURO (2017)

Review Oncology

Androgen receptor in estrogen receptor positive breast cancer: Beyond expression

Debora Basile et al.

CANCER TREATMENT REVIEWS (2017)

Article Oncology

Intracrine androgen biosynthesis in renal cell carcinoma

Geun Taek Lee et al.

BRITISH JOURNAL OF CANCER (2017)

Article Otorhinolaryngology

Salivary duct carcinoma: Clinicopathologic features, morphologic spectrum, and somatic mutations

Peter P. Luk et al.

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2016)

Review Oncology

Clinical Utility of Circulating Tumor Cells in Advanced Prostate Cancer

Tian Zhang et al.

CURRENT ONCOLOGY REPORTS (2016)

Editorial Material Andrology

Androgen receptor splice variants and polycystic ovary syndrome: cause or effect?

Kirsty A. Walters et al.

ASIAN JOURNAL OF ANDROLOGY (2016)

Review Oncology

Emerging data on androgen receptor splice variants in prostate cancer

Subing Cao et al.

ENDOCRINE-RELATED CANCER (2016)

Review Urology & Nephrology

Androgen receptor splice variant 7 in castration-resistant prostate cancer: Clinical considerations

Alan H. Bryce et al.

INTERNATIONAL JOURNAL OF UROLOGY (2016)

Review Urology & Nephrology

Androgen receptor targeted therapies in castration-resistant prostate cancer: Bench to clinic

Yusuke Imamura et al.

INTERNATIONAL JOURNAL OF UROLOGY (2016)

Review Oncology

Androgen receptor variant-driven prostate cancer: clinical implications and therapeutic targeting

E. S. Antonarakis et al.

PROSTATE CANCER AND PROSTATIC DISEASES (2016)

Article Oncology

Regulation of androgen receptor splice variant AR3 by PCGEM1

Ziqiang Zhang et al.

ONCOTARGET (2016)

Review Oncology

Cancer Hallmarks, Biomarkers and Breast Cancer Molecular Subtypes

Xiaofeng Dai et al.

JOURNAL OF CANCER (2016)

Review Oncology

Sexual dimorphism in cancer

Andrea Clocchiatti et al.

NATURE REVIEWS CANCER (2016)

Article Pathology

Molecular Characterization of Apocrine Salivary Duct Carcinoma

Simion I. Chiosea et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2015)

Review Gastroenterology & Hepatology

Gender disparity in chronic hepatitis B: Mechanisms of sex hormones

Sheng-Han Wang et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2015)

Article Multidisciplinary Sciences

Androgen Receptor and Histone Lysine Demethylases in Ovine Placenta

Ellane R. Cleys et al.

PLOS ONE (2015)

Article Multidisciplinary Sciences

Alternative splicing of the androgen receptor in polycystic ovary syndrome

Fangfang Wang et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)

Review Oncology

Targeting the relaxin hormonal pathway in prostate cancer

Anton Neschadim et al.

INTERNATIONAL JOURNAL OF CANCER (2015)

Article Oncology

PD-L1 is highly expressed in Enzalutamide resistant prostate cancer

Jennifer L. Bishop et al.

ONCOTARGET (2015)

Review Developmental Biology

Role of androgens in normal and pathological ovarian function

K. A. Walters

REPRODUCTION (2015)

Article Fisheries

Fish granulocytes express a constitutively active androgen receptor variant

Miriam Sanchez-Hernandez et al.

DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY (2014)

Article Endocrinology & Metabolism

The polycystic ovary syndrome: a position statement from the European Society of Endocrinology

Gerard Conway et al.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2014)

Article Biochemistry & Molecular Biology

Androgen receptor and its splice variant, AR-V7, differentially regulate FOXA1 sensitive genes in LNCaP prostate cancer cells

William C. Krause et al.

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2014)

Article Biochemistry & Molecular Biology

Androgen Receptor Splice Variant AR3 Promotes Prostate Cancer via Modulating Expression of Autocrine/Paracrine Factors

Feng Sun et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2014)

Article Biochemistry & Molecular Biology

Menopausal hormone therapy and breast cancer

Richard J. Santen

JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2014)

Article Obstetrics & Gynecology

Rapid response of breast cancer to neoadjuvant intramammary testosterone-anastrozole therapy: neoadjuvant hormone therapy in breast cancer

Rebecca L. Glaser et al.

MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2014)

Article Biochemistry & Molecular Biology

Mechanisms of the androgen receptor splicing in prostate cancer cells

L. L. Liu et al.

ONCOGENE (2014)

Article Multidisciplinary Sciences

Androgens alter T-cell immunity by inhibiting T-helper 1 differentiation

Haydn T. Kissick et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)

Article Gastroenterology & Hepatology

Molecular mechanisms of gender disparity in hepatitis B virus-associated hepatocellular carcinoma

Wei-Cheng Liu et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2014)

Article Medicine, Research & Experimental

An androgen receptor N-terminal domain antagonist for treating prostate cancer

Jae-Kyung Myung et al.

JOURNAL OF CLINICAL INVESTIGATION (2013)

Review Oncology

On the Origins of the Androgen Receptor Low Molecular Weight Species

Maria Mudryj et al.

HORMONES & CANCER (2013)

Review Immunology

Sex differences in spontaneous versus induced animal models of autoimmunity

Tai-Ping Lee et al.

AUTOIMMUNITY REVIEWS (2012)

Review Endocrinology & Metabolism

The Androgen Receptor in Breast Tissues: Growth Inhibitor, Tumor Suppressor, Oncogene?

T. E. Hickey et al.

MOLECULAR ENDOCRINOLOGY (2012)

Article Medicine, General & Internal

Australian national birthweight percentiles by sex and gestational age, 1998-2007

Timothy A. Dobbins et al.

MEDICAL JOURNAL OF AUSTRALIA (2012)

Article Endocrinology & Metabolism

The Human Placenta Expresses CYP17 and Generates Androgens De Novo

J. C. Escobar et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)

Article Medicine, Research & Experimental

Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant

Shihua Sun et al.

JOURNAL OF CLINICAL INVESTIGATION (2010)

Article Endocrinology & Metabolism

Granulosa Cell-Specific Androgen Receptors Are Critical Regulators of Ovarian Development and Function

Aritro Sen et al.

MOLECULAR ENDOCRINOLOGY (2010)

Article Developmental Biology

Association of AR rs6152G/A gene polymorphism with susceptibility to polycystic ovary syndrome in Chinese women

C. Y. Peng et al.

REPRODUCTION FERTILITY AND DEVELOPMENT (2010)

Review Urology & Nephrology

Relaxin and the progression of kidney disease

Chrishan S. Samuel et al.

CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2009)

Review Urology & Nephrology

Androgen deprivation therapy: progress in understanding mechanisms of resistance and optimizing androgen depletion

William P. Harris et al.

NATURE CLINICAL PRACTICE UROLOGY (2009)

Article Gastroenterology & Hepatology

Androgen receptor is a new potential therapeutic target for the treatment of hepatocellular carcinoma

Cheng-Lung Ma et al.

GASTROENTEROLOGY (2008)

Review Behavioral Sciences

Classical androgen receptors in non-classical sites in the brain

Sara Sarkey et al.

HORMONES AND BEHAVIOR (2008)

Article Endocrinology & Metabolism

Association of androgen receptor CAG repeat polymorphism and polycystic ovary syndrome

Nissar A. Shah et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)

Review Endocrinology & Metabolism

The intersection of steroid receptors with molecular chaperones: Observations and questions

David F. Smith et al.

MOLECULAR ENDOCRINOLOGY (2008)

Review Gastroenterology & Hepatology

Role of sex steroid receptors in pathobiology of hepatocellular carcinoma

Mamta Kalra et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2008)

Article Oncology

Assessing individual risk for breast cancer: role of oestrogens and androgens

Richard J. Santen

BREAST CANCER RESEARCH (2008)

Review Medicine, General & Internal

Polycystic ovary syndrome

Robert J. Norman et al.

LANCET (2007)

Review Developmental Biology

Alternative RNA splicing regulation in the testis

David J. Elliott et al.

REPRODUCTION (2006)

Article Cell Biology

Ca2+ oscillations induced by testosterone enhance neurite outgrowth

M Estrada et al.

JOURNAL OF CELL SCIENCE (2006)

Article Endocrinology & Metabolism

The nuclear receptor superfamily: A Rosetta Stone for physiology

RM Evans

MOLECULAR ENDOCRINOLOGY (2005)

Article Biochemistry & Molecular Biology

Androgen receptor function is modulated by the tissue-specific AR45 variant

I Ahrens-Fath et al.

FEBS JOURNAL (2005)

Article Endocrinology & Metabolism

Membrane androgen receptor activation induces apoptotic regression of human prostate cancer cells in vitro and in vivo

A Hatzoglou et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)

Article Biochemistry & Molecular Biology

Differential distribution of splice variants of estrogen receptor beta in human testicular cells suggests specific functions in spermatogenesis

EL Aschim et al.

JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2004)

Article Multidisciplinary Sciences

Subfertility and defective folliculogenesis in female mice lacking androgen receptor

YC Hu et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)

Review Geriatrics & Gerontology

Postmenopausal testosterone therapy and breast cancer risk

W Somboonporn et al.

MATURITAS (2004)

Article Urology & Nephrology

Relaxin-1-deficient mice develop an age-related progression of renal fibrosis

CS Samuel et al.

KIDNEY INTERNATIONAL (2004)

Article Endocrinology & Metabolism

A role for acidophilic granulocytes in the testis of the gilthead seabream (Sparus aurata L., Teleostei)

E Chaves-Pozo et al.

JOURNAL OF ENDOCRINOLOGY (2003)

Article Biochemistry & Molecular Biology

Novel isoforms of the mRNA for human female sex steroid hormone receptors

S Hirata et al.

JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2002)

Article Biochemistry & Molecular Biology

Cloning of the novel isoform of the estrogen receptor beta cDNA (ERβ isoform M cDNA) from the human testicular cDNA library

T Shoda et al.

JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2002)

Article Oncology

Androgen receptor status in female breast cancer:: RT-PCR and Western blot studies

M Brys et al.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2002)

Article Multidisciplinary Sciences

T cell infiltration of the prostate induced by androgen withdrawal in patients with prostate cancer

M Mercader et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)

Article Biochemistry & Molecular Biology

An estrogen receptor β isoform that lacks exon 5 has dominant negative activity on both ERα and ERβ

S Inoue et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)